| | Issue Date | Title | Author(s) |
| 21 | Jul-2020 | The natural flavonoid galangin ameliorates dextran sulphate sodium-induced ulcerative colitis in mice: Effect on Toll-like receptor 4, inflammation and oxidative stress | Gerges, Samar H; Tolba, Mai ; Elsherbiny, Doaa A; El-Demerdash, Ebtehal |
| 22 | 1-Dec-2020 | Revolutionizing the landscape of colorectal cancer treatment: The potential role of immune checkpoint inhibitors | Tolba, Mai |
| 23 | 15-Dec-2020 | Caffeic acid phenethyl ester counteracts doxorubicin-induced chemobrain in Sprague-Dawley rats: Emphasis on the modulation of oxidative stress and neuroinflammation | Ali, Marwa A; Menze, Esther ; Tadros, Marianne G; Tolba, Mai |
| 24 | 2021 | SARS-CoV-2 Viral Shedding and Transmission Dynamics: Implications of WHO COVID-19 Discharge Guidelines | Badu, Kingsley; Oyebola, Kolapo; Zahouli, Julien Z B; Fagbamigbe, Adeniyi Francis; de Souza, Dziedzom K; Dukhi, Natisha; Amankwaa, Ebenezer F; Tolba, Mai ; Sylverken, Augustina A; Mosi, Lydia; Mante, Priscilla Kolibea; Matoke-Muhia, Damaris; Goonoo, Nowsheen |
| 25 | 2021 | Rosuvastatin and low-dose carvedilol combination protects against isoprenaline-induced myocardial infarction in rats: Role of PI3K/Akt/Nrf2/HO-1 signalling | Baraka, Sarah A; Tolba, Mai ; Elsherbini, Doaa A; El-Naga RN ; Awad, Azza S; El-Demerdash, Ebtehal |
| 26 | 2021 | Editorial: Immunotherapy as an Evolving Approach for the Treatment of Breast Cancer | Tolba, Mai ; Santa-Maria, Cesar A; Albini, Adriana; Chimusa, Emile R; Al-Ramadi, Basel K; Tolaney, Sara M |
| 27 | 2021 | Correlating WHO COVID-19 interim guideline 2020.5 and testing capacity, accuracy, and logistical challenges in Africa | Mosi, Lydia; Sylverken, Augustina Angelina; Oyebola, Kolapo; Badu, Kingsley; Dukhi, Natisha; Goonoo, Nowsheen; Mante, Priscilla Kolibea; Zahouli, Julien; Amankwaa, Ebenezer Forkuo; Tolba, Mai ; Fagbamigbe, Adeniyi Francis; de Souza, Dziedzom Komi; Matoke-Muhia, Damaris |
| 28 | 1-May-2021 | Nuclear factor-κB signaling inhibitors revert multidrug-resistance in breast cancer cells | Abdin, Shifaa M; Tolba, Mai ; Zaher, Dana M; Omar, Hany A |
| 29 | Oct-2021 | Novel combinatorial strategies for boosting the efficacy of immune checkpoint inhibitors in advanced breast cancers | Tolba, Mai ; Elghazaly, H; Bousoik, E; Elmazar, M M A; Tolaney, S M |
| 30 | 5-Jan-2022 | The potential neuroprotective effect of diosmin in rotenone-induced model of Parkinson's disease in rats | Habib, Christine N; Tadros, Mariane G; Tolba, Mai ; Menze, Esther ; Masoud, Somia I; Mohamed, Mohamed R |
| 31 | Mar-2022 | The natural isoflavone Biochanin-A synergizes 5-fluorouracil anticancer activity in vitro and in vivo in Ehrlich solid-phase carcinoma model | Mahmoud, Mohamed; Abdollah, Maha R A; Elsesy, Mohamed E; Abou El Ella, Dalal ; Zada, Suher K; Tolba, Mai |
| 32 | Mar-2022 | Implications of WHO COVID-19 interim guideline 2020.5 on the comprehensive care for infected persons in Africa Before, during and after clinical management of cases | Fagbamigbe, Adeniyi Francis; Tolba, Mai ; Amankwaa, Ebenezer F; Mante, Priscilla Kolibea; Sylverken, Augustina Angelina; Zahouli, Julien Z B; Goonoo, Nowsheen; Mosi, Lydia; Oyebola, Kolapo; Matoke-Muhia, Damaris; de Souza, Dziedzom K; Badu, Kingsley; Dukhi, Natisha |
| 33 | Jul-2022 | Insights into the therapeutic potential of histone deacetylase inhibitor/immunotherapy combination regimens in solid tumors | Sedky, Nada K; Hamdan, Alyaa A; Emad, Salma; Allam, Aya L; Ali, Mohamed; Tolba, Mai |
| 34 | 2023 | Editorial: Emerging talents in pharmacology of anti-cancer drugs 2022 | Khan, Husain Yar; Bajbouj, Khuloud; Tolba, Mai |
| 35 | 1-Sep-2023 | Insights into the therapeutic outcomes of trimetazidine/doxorubicin combination in Ehrlich solid-phase carcinoma mouse tumor model | Abdeljalil, Somaya M; Wahdan, Sara A; Elghazaly, Hesham; Tolba, Mai |